Penumbra PEN
NYSE PEN
$319.81 +0.55 (+0.17%)
As of: Sep 9, 2026 · 12:54 PM EDT

Penumbra (PEN) Cost of Revenue (2014 - 2026)

Penumbra's (PEN) quarterly Cost of Revenue came in at $125.1 million in Q2 2026, up 8.37% year-over-year from $115.4 million in Q2 2025, and up 3.09% quarter-over-quarter from $121.3 million in Q1 2026.

Analysis

Penumbra (PEN) Cost of Revenue (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Cost of Revenue for 13 consecutive years, with $125.1 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cost of Revenue rose 8.37% year-over-year to $125.1 million in Q2 2026; TTM through Jun 2026 was $484.0 million, a 12.75% increase from a year earlier, with the FY2025 full-year figure at $461.2 million, up 4.92% from the prior year.
  • Cost of Revenue was $125.1 million for Q2 2026 at Penumbra, up from $121.3 million in the prior quarter.
  • Over five years, Cost of Revenue peaked at $136.6 million in Q2 2024 and troughed at $74.3 million in Q2 2022.
  • A 5-year average of $102.0 million and a median of $99.2 million in 2023 frame the typical range for Cost of Revenue.
  • Across the five-year window, Cost of Revenue soared 44.31% in 2024 and fell 15.47% in 2025, its largest moves.
  • Over 5 years, Cost of Revenue stood at $82.8 million in 2022, then gained by 18.0% to $97.7 million in 2023, then gained by 7.28% to $104.8 million in 2024, then climbed by 17.62% to $123.3 million in 2025, then grew by 1.5% to $125.1 million in 2026.
  • The last three Cost of Revenue figures came in at $125.1 million (Q2 2026), $121.3 million (Q1 2026), and $123.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn 5.33 Bn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn 931.90 Mn
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn 3.42 Bn
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn 2.09 Bn
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn 1.59 Bn
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn 392.40 Mn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn 18.00 Mn
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn 478.40 Mn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn 808.60 Mn
10 Penumbra 12.58 Bn 11.92 Bn 264.94 Mn 125.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 125.10 Mn
Mar 31, 2026 121.35 Mn
Dec 31, 2025 123.26 Mn
Sep 30, 2025 114.27 Mn
Jun 30, 2025 115.45 Mn
Mar 31, 2025 108.26 Mn
Dec 31, 2024 104.80 Mn
Sep 30, 2024 100.73 Mn
Jun 30, 2024 136.57 Mn
Mar 31, 2024 97.52 Mn
Dec 31, 2023 97.69 Mn
Sep 30, 2023 93.23 Mn
Jun 30, 2023 94.64 Mn
Mar 31, 2023 90.33 Mn
Dec 31, 2022 82.79 Mn
Sep 30, 2022 78.35 Mn
Jun 30, 2022 74.31 Mn
Mar 31, 2022 76.48 Mn
Dec 31, 2021 78.56 Mn
Sep 30, 2021 70.21 Mn